SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

23 Jul 2025 Evaluate
The Sales for the quarter ended June 2025 of Rs. 15.43 million declined by -1795.60% from Rs. -0.91 millions.The Total Profit for the quarter ended June 2025 of Rs. 13.45 millions grew from Rs.-1.59 millions Operating profit Margin for the quarter ended June 2025 improved to 13.45% as compared to -1.59% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 15.43 -0.91 -1795.60 15.43 -0.91 -1795.60 8.38 23.82 -64.82
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 13.45 -1.59 -945.91 13.45 -1.59 -945.91 -2.93 19.31 -115.17
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 13.45 -1.59 -945.91 13.45 -1.59 -945.91 -2.93 19.31 -115.17
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 13.45 -1.59 -945.91 13.45 -1.59 -945.91 -2.93 19.31 -115.17
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 13.45 -1.59 -945.91 13.45 -1.59 -945.91 -2.93 19.31 -115.17
Equity 902.60 652.60 38.31 902.60 652.60 38.31 652.60 652.60 0.00
PBIDTM(%) 87.17 174.73 -50.11 87.17 174.73 -50.11 -34.96 81.07 -143.13

Biogen Pharmachem Share Price

0.47 0.01 (2.17%)
06-May-2026 11:30 View Price Chart
Peers
Company Name CMP
Redington 220.75
Adani Enterprises 2496.00
Amrapali Industries 17.90
Rashi Peripheral 507.10
PDS 286.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×